Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF771 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
mRNA | ZNF773 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | ZNF775 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | ZNF778 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
mRNA | ZNF786 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | ZNF821 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | ZNF837 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
mRNA | ZNRD1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.04 |
mRNA | ZSCAN26 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
mRNA | ZYG11A | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |